| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 214,2 k € | +26.2% | 169,8 k € | +8.0% | 157,2 k € | -12.5% | 179,5 k € | +3.9% | 172,7 k € | +5.9% | 163,2 k € | -43.2% | 287,5 k € | +3857.4% | -7,7 k € | -102.3% | 327,4 k € | -56.9% | 760,4 k € | +36.0% | 558,9 k € | +67.6% | 333,4 k € | +31.2% | 254,2 k € | -22.8% | 329,2 k € | +3.1% | 319,4 k € | -11.5% | 361,0 k € | -16.3% | 431,4 k € | +14.8% | 375,7 k € | |
| EBITDA | 204,0 k € | +28.1% | 159,2 k € | +8.4% | 146,9 k € | -15.0% | 172,7 k € | +3.7% | 166,5 k € | +6.1% | 157,0 k € | -44.2% | 281,6 k € | +1521.0% | -19,8 k € | -106.3% | 316,2 k € | -57.8% | 749,8 k € | +35.6% | 553,2 k € | +69.2% | 326,9 k € | +32.6% | 246,6 k € | -22.9% | 319,8 k € | +3.3% | 309,5 k € | -13.0% | 355,8 k € | -16.3% | 425,1 k € | +14.9% | 370,0 k € | |
| Operating profit | 155,5 k € | +38.6% | 112,2 k € | +104.6% | 54,8 k € | -38.4% | 89,1 k € | +8.5% | 82,0 k € | +12.0% | 73,3 k € | -63.0% | 197,8 k € | +253.0% | -129,3 k € | -161.3% | 211,0 k € | -67.2% | 644,1 k € | +25.5% | 513,2 k € | +87.8% | 273,2 k € | +41.2% | 193,6 k € | -24.7% | 257,1 k € | +4.6% | 245,8 k € | -23.9% | 322,9 k € | -17.9% | 393,1 k € | +17.5% | 334,5 k € | |
| Profit/loss | 137,3 k € | +12.9% | 121,6 k € | +221.0% | 37,9 k € | -25.2% | 50,6 k € | -3.3% | 52,3 k € | +35.0% | 38,8 k € | -67.2% | 118,3 k € | +191.1% | -129,8 k € | -198.4% | 132,0 k € | -68.5% | 419,2 k € | +21.7% | 344,3 k € | +80.4% | 190,8 k € | +44.6% | 131,9 k € | -21.8% | 168,6 k € | +7.3% | 157,2 k € | -26.1% | 212,8 k € | -16.0% | 253,4 k € | +20.4% | 210,5 k € | |
| Equity | 3,4 M € | +4.3% | 3,2 M € | -3.4% | 3,3 M € | +1.1% | 3,3 M € | +1.6% | 3,3 M € | +1.6% | 3,2 M € | +1.2% | 3,2 M € | +14.3% | 2,8 M € | -4.5% | 2,9 M € | +4.8% | 2,8 M € | +42.1% | 1,9 M € | +15.6% | 1,7 M € | +12.8% | 1,5 M € | +9.7% | 1,4 M € | +14.2% | 1,2 M € | +15.2% | 1,0 M € | +26.0% | 819,6 k € | +44.8% | 566,2 k € | |
| Total assets | 3,7 M € | +4.2% | 3,5 M € | +2.7% | 3,4 M € | +0.1% | 3,4 M € | +3.2% | 3,3 M € | +0.6% | 3,3 M € | +0.2% | 3,3 M € | +8.0% | 3,0 M € | -4.6% | 3,2 M € | +2.8% | 3,1 M € | +40.4% | 2,2 M € | +4.9% | 2,1 M € | +5.6% | 2,0 M € | +17.5% | 1,7 M € | +2.5% | 1,7 M € | +5.8% | 1,6 M € | +2.5% | 1,5 M € | +17.3% | 1,3 M € | |
| Cash | 131,9 k € | +150.7% | 52,6 k € | -79.5% | 256,2 k € | -84.4% | 1,6 M € | +36.2% | 1,2 M € | +9.4% | 1,1 M € | +15.2% | 959,6 k € | +193.2% | 327,3 k € | +15.5% | 283,3 k € | +188.4% | 98,2 k € | -17.7% | 119,4 k € | -81.7% | 650,8 k € | +7.9% | 603,2 k € | +53.0% | 394,3 k € | +34.8% | 292,6 k € | -45.8% | 539,9 k € | +7.6% | 501,7 k € | +90.6% | 263,2 k € | |
| Debts | 278,5 k € | +3.8% | 268,3 k € | +332.0% | 62,1 k € | -33.4% | 93,2 k € | +137.2% | 39,3 k € | -46.5% | 73,4 k € | -30.9% | 106,2 k € | -58.2% | 254,3 k € | -6.0% | 270,7 k € | -14.6% | 317,0 k € | +21.4% | 261,1 k € | -38.0% | 421,0 k € | -16.0% | 501,1 k € | +49.0% | 336,4 k € | -27.3% | 462,9 k € | -12.2% | 527,1 k € | -24.8% | 700,6 k € | -4.0% | 729,8 k € | |
Private limited company · Brugge · incorporated on 09/12/1997
Private limited company profitable and well capitalised. Cash position rising (+150.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Peter Van Oyen is a Private limited company incorporated in 1997. Its main activity is: Specialist medical practice activities. Its registered office is in Brugge.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette